Experts attending the ongoing 25th International AIDS Conference in Germany have commended the results from the PURPOSE 1 trial of twice-yearly injectable Lenacapavir for Human Immunodeficiency Virus (HIV) prevention. An
The post Experts hail trial results of injectable Lenacapavir for HIV prevention appeared first on The Nation Newspaper… Read More
